Nebivolol induced vasodilation of renal afferent arterioles involves β3 adrenergic receptor and nitric oxide synthase activation.
Am J Physiol Renal Physiol. 2012 Jun 6
John Imig
12 Jul 2012
|
Confirmation
These experimental studies provide evidence that the B1 adrenergic receptor blocker nebivolol dilates renal afferent and efferent arterioles via activation of B3 adrenergic receptors. Additional experiments demonstrate that nevibolol renal arteriolar dilation is mediated by nitric oxide. Thus, these studies add to previous reports...
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.